Drug–Drug, Drug–Disease and Disease–Disease Interactions in COVID-19 with Cardiovascular Diseases (CVDs)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Drug–Drug, Drug–Disease and Disease–Disease Interactions in COVID-19 with Cardiovascular Diseases (CVDs) ; volume:5 ; number:03 ; year:2020 ; pages:216-222
Indian Journal of Cardiovascular Disease in Women WINCARS ; 5, Heft 03 (2020), 216-222
- Beteiligte Personen und Organisationen
-
Jyotsna, M.
Hemalatha, Y.
- DOI
-
10.1055/s-0040-1716786
- URN
-
urn:nbn:de:101:1-2020122110505954783911
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jyotsna, M.
- Hemalatha, Y.
Ähnliche Objekte (12)
Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States
Potential drug–drug interactions in patients with cardiovascular diseases: findings from a prospective observational study
Randomized prospective trial to detect and distinguish between medication nonadherence, drug-drug interactions, and disease progression in chronic cardiometabolic disease
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Extracting drug-drug interactions from biomedical texts
Strategies for avoiding typical drug–drug interactions and drug-related problems in patients with vascular diseases
Drug therapy problems among hospitalized patients with cardiovascular disease
Lurasidone drug-drug interaction studies: a comprehensive review
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
Case report: Medical cannabis—warfarin drug-drug interaction
Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States
Potential drug–drug interactions in patients with cardiovascular diseases: findings from a prospective observational study
Randomized prospective trial to detect and distinguish between medication nonadherence, drug-drug interactions, and disease progression in chronic cardiometabolic disease
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Extracting drug-drug interactions from biomedical texts
Strategies for avoiding typical drug–drug interactions and drug-related problems in patients with vascular diseases
Drug therapy problems among hospitalized patients with cardiovascular disease
Lurasidone drug-drug interaction studies: a comprehensive review
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
Case report: Medical cannabis—warfarin drug-drug interaction
Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States
Potential drug–drug interactions in patients with cardiovascular diseases: findings from a prospective observational study
Randomized prospective trial to detect and distinguish between medication nonadherence, drug-drug interactions, and disease progression in chronic cardiometabolic disease
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Extracting drug-drug interactions from biomedical texts
Strategies for avoiding typical drug–drug interactions and drug-related problems in patients with vascular diseases
Drug therapy problems among hospitalized patients with cardiovascular disease
Lurasidone drug-drug interaction studies: a comprehensive review
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir